Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action

This publication has 58 references indexed in Scilit:

• Lecanemab: More Questions Than Answers!
  Clinical Drug Investigation, 2023
• Tryptamine: A privileged scaffold for the management of Alzheimer's disease
  Drug Development Research, 2023
• Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
  Apoptosis, 2023
• Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review
  Molecular and Cellular Biochemistry, 2022
• Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s Disease
  Molecular Neurobiology, 2021
• Angiotensin II receptor blocker irbesartan attenuates sleep apnea–induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation
  Sleep and Breathing, 2021
• Apoptosis and its therapeutic implications in neurodegenerative diseases
  Clinical Anatomy, 2021
• Irbesartan mitigates acute liver injury, oxidative stress, and apoptosis induced by acetaminophen in mice
  Journal of Biochemical and Molecular Toxicology, 2020
• LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer’s Disease
  Molecular Neurobiology, 2019
• Monocyte chemoattractant protein-1 and the blood–brain barrier
  Cellular and Molecular Life Sciences, 2013